Status: current, Defined. Date: 30-Sep 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4199151000168115 | Aprepitant (Apotex) (aprepitant 165 mg) capsule, 1 capsule, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4199161000168118 | Aprepitant (Apotex) 165 mg capsule, 1, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | Is a | Aprepitant (Apotex) 165 mg capsule, 1 | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | has TPUU | Aprepitant (Apotex) 165 mg capsule | true | Inferred relationship | Some | 1 | |
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Aprepitant (Apotex) 165 mg capsule, 1, blister pack | has TP | Aprepitant (Apotex) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR